Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-30

Clinical Trial Update: Cholinergic Mechanisms of Attentional-motor Integration and Gait Dysfunction in Parkinson Disease (UDALL) [NA]

View source ↗

Summary

A clinical trial update on cholinergic mechanisms of attentional-motor integration and gait dysfunction in Parkinson disease (UDALL), currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Michigan | Conditions: Parkinson Disease, Progressive Supranuclear Palsy | NA | Status: ACTIVE_NOT_RECRUITING